# Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.

> **NCT03981679** · NA · COMPLETED · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 278 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** Biological collection

## Key facts

- **NCT ID:** NCT03981679
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-05
- **Primary completion:** 2020-01-17
- **Final completion:** 2020-01-17
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2020-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981679, "Circulating-free DNA Assessment as a Tool to Predict Colorectal Cancer in Subjects With a Positive Fecal Immunoassay.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03981679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*